Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 3, 2025

Dec. 3, 2025

Elevar Therapeutics Announces Publication of CARES-310 Study Final Analysis in The Lancet Oncology

GlobeNewswire

Dec. 3, 2025

BetaGlue Therapeutics erweitert klinische Studie in Italien nach Genehmigung vom italienischen Gesundheitsministerium zur Durchführung einer klinischen Studie bei nicht resezierbarem, lokal fortgeschrittenem Bauchspeicheldrüsenkrebs (uLA-PDAC)

GlobeNewswire

Dec. 3, 2025

BetaGlue Therapeutics étend son essai clinique en Italie après avoir obtenu l’autorisation du ministère de la Santé italien pour mener son étude clinique sur le cancer du pancréas localement avancé non résécable (uLA-PDAC)

GlobeNewswire

Dec. 3, 2025

Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product

GlobeNewswire

Dec. 3, 2025

Longeveron Chief Science Officer and Chief Medical Officer Selected as Speakers at the Global CardioVascular Clinical Trialists (CVCT) Forum

GlobeNewswire

Dec. 3, 2025

Wesley Pharmaceuticals Unveils First Product, Zinc Sulfate, Revolutionizing Wellness Solutions

GlobeNewswire

Dec. 3, 2025

Brevard Health Alliance Improves Hypertension Control with RPM Program Utilizing Rimidi's Platform and Connected Devices

GlobeNewswire

Dec. 3, 2025

Aeroflow Urology Donates $30,000 to Support Family-Centered Care

GlobeNewswire

Dec. 3, 2025

Muscular Dystrophy Association Announces nearly $2 Million in Collaborative Research Grants Advancing Treatments Across Multiple Neuromuscular Diseases

GlobeNewswire

Dec. 3, 2025

Oncotelic and Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing

GlobeNewswire

Dec. 3, 2025

Extendicare Completes Previously Announced $200 Million Private Placement of Common Shares

GlobeNewswire

Dec. 3, 2025

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™

GlobeNewswire

Dec. 3, 2025

Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology

GlobeNewswire

$Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI®) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia$

Dec. 3, 2025